Biomarin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?
BIOMARIN PHARM has three approved drugs.
There are fourteen US patents protecting BIOMARIN PHARM drugs.
There are one hundred and sixty-two patent family members on BIOMARIN PHARM drugs in thirty countries and nine supplementary protection certificates in nine countries.
Summary for Biomarin Pharm
International Patents: | 162 |
US Patents: | 14 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 3 |
Patent Litigation for Biomarin Pharm: | See patent lawsuits for Biomarin Pharm |
Drugs and US Patents for Biomarin Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | AB | RX | Yes | Yes | 7,727,987*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-002 | Nov 19, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Biomarin Pharm | KUVAN | sapropterin dihydrochloride | POWDER;ORAL | 205065-002 | Oct 27, 2015 | AB | RX | Yes | No | 7,566,714*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2014-05-30 |
➤ Subscribe | Powder for Oral Solution | 500 mg/packet | ➤ Subscribe | 2016-12-20 |
➤ Subscribe | Powder for Oral Solution | 100 mg per packet | ➤ Subscribe | 2015-11-09 |
International Patents for Biomarin Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | PI0809470 | ⤷ Try a Trial |
Canada | 2711160 | ⤷ Try a Trial |
Denmark | 3175863 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Biomarin Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2432489 | C202230004 | Spain | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE; NATIONAL AUTHORISATION NUMBER: EU/1/21/1577; DATE OF AUTHORISATION: 20210826; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1577; DATE OF FIRST AUTHORISATION IN EEA: 20210826 |
2432489 | 2290005-4 | Sweden | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE; REG. NO/DATE: EU/1/21/1577 20210921 |
2432489 | 301162 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE IN IEDERE VORM ZOALS BESCHERMD DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/21/1577 20210901 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.